Guided Therapeutics (GTHP) Cash from Operations Growth (5y) (2021 - 2025)
Guided Therapeutics (GTHP) Cash from Operations Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.54% |
| Sep 30, 2025 | 14.49% |
| Jun 30, 2025 | 16.16% |
| Mar 31, 2025 | 8.99% |
| Dec 31, 2024 | -10.23% |
| Sep 30, 2024 | -15.71% |
| Jun 30, 2024 | -2.62% |
| Mar 31, 2024 | 11.67% |
| Dec 31, 2023 | -1.56% |
| Sep 30, 2023 | -2.55% |
| Jun 30, 2023 | -12.60% |
| Mar 31, 2023 | -4.79% |
| Dec 31, 2022 | 12.55% |
| Sep 30, 2022 | -24.57% |
| Jun 30, 2022 | -36.19% |
| Mar 31, 2022 | 15.15% |
| Dec 31, 2021 | 22.93% |